Insiders Revolution Medicines, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 03:47:35 2024-04-29 pm EDT			5-day change	1st Jan Change
37.08 ^USD	+3.11%		+1.48%	+28.91%

Apr. 12	Oppenheimer Adjusts Revolution Medicines Price Target to $45 From $43, Maintains Outperform Rating	MT
Apr. 12	Needham Adjusts Revolution Medicines' Price Target to $46 From $36, Keeps Buy Rating	MT

Revolution Medicines Insider Sold Shares Worth $805,652, According to a Recent SEC Filing	Mar. 13	MT
Revolution Medicines Insider Sold Shares Worth $387,884, According to a Recent SEC Filing	Jan. 04	MT
Revolution Medicines Insider Sold Shares Worth $966,996, According to a Recent SEC Filing	Dec. 29	MT
Revolution Medicines Insider Sold Shares Worth $125,000, According to a Recent SEC Filing	Dec. 08	MT
Revolution Medicines, Inc. Appoints Sandra J. Horning, M.D., as Member of the Board	Nov. 09	CI
Revolution Medicines Insider Sold Shares Worth $848,806, According to a Recent SEC Filing	23-10-18	MT
Revolution Medicines Insider Sold Shares Worth $484,130, According to a Recent SEC Filing	23-10-13	MT
Revolution Medicines Insider Sold Shares Worth $252,175, According to a Recent SEC Filing	23-09-20	MT
Revolution Medicines Insider Sold Shares Worth $239,123, According to a Recent SEC Filing	23-09-19	MT
Insider Sell: Revolution Medicines	23-09-07	MT
Revolution Medicines, Inc. Resigns Eric T. Schmidt as Board of Directors	23-09-05	CI
Insider Sell: Revolution Medicines	23-09-01	MT
Insider Sell: Revolution Medicines	23-08-17	MT
Insider Sell: Revolution Medicines	23-08-03	MT
Revolution Medicines, Inc. Announces Executives Appointment	23-05-08	CI
Insider Buy: Revolution Medicines	23-03-13	MT
Insider Sell: Revolution Medicines	22-11-02	MT
Insider Sell: Revolution Medicines	22-10-28	MT
Revolution Medicines Appoints Jack Anders CFO, Daniel Simon Chief Business Officer	22-09-01	MT
Revolution Medicines, Inc. Announces Executive Changes	22-09-01	CI

No results for this search